6505-01-287-4220 ( NDC00003-1315-37 , ISOVUE-300 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-287-4220 | 6505 | 012874220 | IOPAMIDOL INJECTION | 3771 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| PKTY | UNIT PACKAGE TYPE | PACKAGE |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| FEAT | SPECIAL FEATURES | CONTAINS 612 MG IOPAMIDOL AND 1 MG TROMETHAMINE PER ML |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 150.000 MILLILITERS |
| CQCT | PRIMARY CONTAINER TYPE | VIAL, SINGLE DOSE |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 61.000 PERCENTAGE, W/V IOPAMIDOL ACTIVE INGREDIENT |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC00003-1315-37 | 78473 | F | 2 | 3 | 4 | KX | |
| ISOVUE-300 | 78473 | F | 1 | 5 | 4 | KX |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC00003-1315-37 | 78473 | SQUIBB E R AND SONS INC | A | F |
| ISOVUE-300 | 78473 | SQUIBB E R AND SONS INC | A | F |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | X | A | 1 | 10/21/1 | Y | 3771 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| DN | 9L----- | N | V | DISCONTINUED W/O REPLACEMENT | |
| DN | 9L----- | N | K | U/I CONTAINS 10 EA |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | A | Y | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| DN | S9M | Y | 1 | PG | Q | U | 9L----- | N |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|